Related references
Note: Only part of the references are listed.The Missing Diversity in Human Genetic Studies
Giorgio Sirugo et al.
CELL (2019)
Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research
Rachel Huddart et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirements
Karla I. Claudio-Campos et al.
PHARMACOGENOMICS (2019)
Admixture, Genetics and Complex Diseases in Latin Americans and US Hispanics
Giordano Soares-Souza et al.
CURRENT GENETIC MEDICINE REPORTS (2018)
Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics
Maria-Eugenia G. Naranjo et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2018)
Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment
M. M. Jukic et al.
MOLECULAR PSYCHIATRY (2017)
High frequency of CYP2D6 ultrarapid metabolizer genotypes in an Ashkenazi Jewish population from Argentina
G. Moya et al.
PHARMACOGENOMICS JOURNAL (2017)
Lessons from Cuba for Global Precision Medicine: CYP2D6 Genotype Is Not a Robust Predictor of CYP2D6 Ultrarapid Metabolism
Pedro Dorado et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2017)
Differential effects of predictors of warfarin dose according to race/color categories in the admixed Brazilian population
Guilherme Suarez-Kurtz et al.
PHARMACOGENETICS AND GENOMICS (2017)
CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?
Fernando de Andres et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2017)
Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations
I. Fricke-Galindo et al.
PHARMACOGENOMICS JOURNAL (2016)
To Genotype or Phenotype for Personalized Medicine? CYP450 Drug Metabolizing Enzyme Genotype-Phenotype Concordance and Discordance in the Ecuadorian Population
Fernando De Andres et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2016)
Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America
Martha Sosa-Macias et al.
PHARMACOGENOMICS (2016)
Admixture and ethno-specific alleles: missing links for global pharmacogenomics
Jorge Duconge et al.
PHARMACOGENOMICS (2016)
Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population
Carolina Céspedes-Garro et al.
REVISTA DE BIOLOGIA TROPICAL (2016)
Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes
Carolina Cespedes-Garro et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration
Paulo Caleb Junior Lima Santos et al.
PHARMACOGENOMICS (2015)
A combined high CYP2D6-CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstances
E. Penas-Lledo et al.
PHARMACOGENOMICS JOURNAL (2015)
Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations
Adrian LLerena et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patients
E. M. Penas-LLedo et al.
MOLECULAR PSYCHIATRY (2013)
Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms
P. Dorado et al.
PHARMACOGENOMICS JOURNAL (2013)
Socioeconomic and Nutritional Factors Account for the Association of Gastric Cancer with Amerindian Ancestry in a Latin American Admixed Population
Latife Pereira et al.
PLOS ONE (2012)
Development of a Panel of Genome-Wide Ancestry Informative Markers to Study Admixture Throughout the Americas
Joshua Mark Galanter et al.
PLOS GENETICS (2012)
CYP2C9 allele frequency differences between populations of Mexican- Mestizo, Mexican- Tepehuano, and Spaniards
P. Dorado et al.
PHARMACOGENOMICS JOURNAL (2011)
Human genome diversity: frequently asked questions
Guido Barbujani et al.
TRENDS IN GENETICS (2010)
Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy
N. A. Limdi et al.
BLOOD CELLS MOLECULES AND DISEASES (2009)
Fast model-based estimation of ancestry in unrelated individuals
David H. Alexander et al.
GENOME RESEARCH (2009)
Comparing genetic ancestry and self-described race in African Americans born in the United States and in Africa
Rona Yaeger et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Pharmacogenetics of Warfarin: Development of a Dosing Algorithm for Brazilian Patients
J. A. Perini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Population structure and eigenanalysis
Nick Patterson et al.
PLOS GENETICS (2006)
QTc interval lengthening is related to CYP2D6 hydroxylation capacity and plasma concentration of thioridazine in patients
A Llerena et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2002)
Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients
R Berecz et al.
PHARMACOPSYCHIATRY (2002)
Share Paper
